Overexpression of VEGF 165 b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

(2010) Mirko Manetti et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth

(2010) Maria Peiris-Pagès et al.   JOURNAL OF PATHOLOGY

The anti-angiogenic isoforms of VEGF in health and disease

(2009) Yan Qiu et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Therapeutic potential of manipulating VEGF splice isoforms in oncology

(2009) Emma S Rennel et al.   Future Oncology

Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma

(2009) L. K. HUMMERS et al.   JOURNAL OF RHEUMATOLOGY

VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

(2008) A H R Varey et al.   BRITISH JOURNAL OF CANCER

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

(2008) E S Rennel et al.   BRITISH JOURNAL OF CANCER

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

(2008) D. G. Nowak et al.   JOURNAL OF CELL SCIENCE